Raffles Medical's Cash Position Leaves Room for M&A -- Market Talk

Dow Jones
02/25

0553 GMT - Raffles Medical's strong net cash position leaves room for potential mergers and acquisitions, says its bull at CGS International. The Singapore hospital operator's net cash, excluding lease liabilities, was S$261.1 million in 2025, says analyst Tay Wee Kuang in a note. This cash also supports the sustainability of its final and total dividend per share of 3.0 Singapore cents, which offers a dividend yield of around 2.8%, above that of regional peers, he says. The analyst trims his earnings-per-share estimates for 2026-2027 by 0.6%-1.2%, citing a projected decline in finance income. CGSI trims its target price for the stock to S$1.20 from S$1.23 and retains its add rating. Shares drop 1.9% to S$1.05. (megan.cheah@wsj.com)

 

(END) Dow Jones Newswires

February 25, 2026 00:53 ET (05:53 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10